Reprocessing of Single Use Devices (SUDs) MEDEC Regulatory Conference May 9, 2016
|
|
- Francis Arnold
- 6 years ago
- Views:
Transcription
1 Reprocessing of Single Use Devices (SUDs) MEDEC Regulatory Conference May 9, 2016
2 Objective and Outline Objective: Health Canada s requirements around licensing of Reprocessed Single Use Devices (RSUDS) Content to be provided in a licence application for RSUDs Outline: Description/definition of RSUDs Regulatory approach to RSUDs Licence applications for Class III/IV devices Expectations and requirements for reprocessors Labelling Device tracking Cleaning validation Device validation
3 Reprocessed Single Use Devices Single-use medical devices (SUDs) are intended by their manufacturers to be used once during a single procedure and not to be cleaned and reused. Reprocessed SUDs are those that have previously been used on a patient and have been subjected to additional processing and manufacturing for the purpose of an additional single use on a patient. Devices that may be candidates for RSUDs: Surgical instruments, drills, burrs, catheters (PTA, EP), compression sleeves, hemodialysis accessories, etc.
4 Reprocessing Single Use Devices Reprocessing a medical device involves cleaning, reconditioning, function testing, and disinfection or sterilisation. A hospital s use of third-party commercial reprocessors may be either: A closed-loop procurement model (the hospital receives only its own devices back from the third-party reprocessor) An open-loop model (the hospital does not get its own devices back but rather buys them from a pool of reprocessed devices).
5 Background on Regulatory Approach will Health be held Canada to the same published a requirements as manufacturers of notice outlining the new devices. This means they must meet regulatory requirements approach for licensing, to quality commercial system management, reprocessing labelling, investigating and handling of SUDs complaints, maintaining distribution records, conducting recalls, reporting incidents and informing Health Canada mps/md-im/activit/announce- annonce/md_notice_sud_uu_avis_i in their licence application. of any changes to the information m-eng.php All RSUDs are to be licensed by September 1, 2017
6 Regulatory Approach Health Canada will issue medical device licences to commercial reprocessors who reprocess SUDs for healthcare facilities. Reprocessed devices will keep the same risk classification as the original equipment manufacturer (OEM) device. Reprocessors must demonstrate that the reprocessed devices they sell meet the safety and effectiveness requirements of the Medical Devices Regulations either directly, or by demonstrating equivalence to a currently licensed device. Reprocessors of licensed SUD s will not be required to demonstrate that the OEM devices meet the safety and effectiveness requirements of the Medical Devices Regulations. Reprocessors of unlicensed SUD s will be required to demonstrate, through the provision of objective evidence, that the OEM devices meet the safety and effectiveness requirements of the Medical Devices Regulations 6
7 Regulatory Approach In addition to the standard medical device licence application package, the reprocessor should submit: 1. An overview specifically outlining whether the device in question is appropriate for reprocessing, including: a. Description of the device b. Detailed risk analysis c. Data analysis of reverse engineering d. Performance specifications (functional specs., cleanliness, SAL, etc.) including a justification that the specifications are appropriate. 2. Complete and detailed description of the entire validated reprocessing process / procedures, including initial decontamination, cleaning, acceptance testing, refurbishing, packaging, labelling, sterilisation, and release. 7
8 Regulatory Approach 3. Validation of post-processing device performance, in accordance with item 1 above, up to the maximum number of cycles, including: a. Acceptance criteria b. Pre-clinical testing c. Biocompatibility, etc. 4. Packaging validation including description of sterile barrier system and stability studies. 5. Product labelling, including IFU s and product marking/etching scheme. 6. A method of tracking the number of processing cycles that have been applied to a given device. 8
9 Regulatory Approach Requirements for licence applications the same as any other manufacturer. Guidance Document: Information to Be Provided by Manufacturers for the Reprocessing and Sterilization of Reusable Medical Devices Guidance Document: Guidance on supporting evidence to be provided for new and amended licence applications for Class III and Class IV medical devices, not including In Vitro Diagnostic Devices (IVDDs)
10 Device Licence Applications - Class III and Class IV 1. Background Information Device Description Design Philosophy Indications 2. Labelling 3. Marketing History Canadian and International Incident Reports 4. Manufacturing and Quality Control Materials Biological materials Quality Plan Manufacturing Process Process Validation Studies Sterilization Validation Bioburden, pyrogen, residuals Packaging Validation 5. Safety and Effectiveness Studies List of standards Preclinical studies Bench testing, shelf life, biocompatibility, animal studies Clinical studies Literature Studies & Bibliography 6. Risk Assessment
11 Expectations for Reprocessors Reprocessors will be required to include their name and address on the labelling of the SUDs they reprocess and will therefore be considered the manufacturer as defined in the MDR. 11
12 Expectations for Reprocessors Section 9 of the MDR requires that the manufacturer ensures that its devices meet the safety and effectiveness requirements (S&E) [Sec.9(1)] and to keep objective evidence to establish that its devices meet the S&E requirements [9(2)]. Reprocessors of all risk classes of RSUD s will therefore be required to maintain objective evidence to demonstrate that their RSUD s meet the S&E requirements of the MDR. 12
13 Expectations for Reprocessors Clause of ISO 13485:2003 requires that a manufacturer establish and maintain, for each type or model of device, a file either containing or identifying documents defining product specifications and quality management system requirements. These documents shall define the complete manufacturing process. 13
14 Expectations for Reprocessors Reprocessors will need to develop a complete, documented set of acceptance criteria and functional requirements for each type and model SUD to be reprocessed. This should include a documented and justified rationale for the suitability of each type and model of SUD for reprocessing. 14
15 Expectations for Reprocessors This also entails a detailed risk analysis covering: the device the maximum number of reprocessing cycles acceptance criteria for incoming used SUD s the decontamination and cleaning process any refurbishment activities functional performance criteria and testing activities packaging and labelling activities the sterilization process tracking the number of reprocessing cycles identifying the device in the field as reprocessed tracking of design changes made by the OEM 15
16 Expectations for Reprocessors Reprocessors are expected to have documented acceptance criteria and functional / performance specifications. Preference is given to using the OEM s specifications. Reverse-engineering of specifications is possible, but this requires justification through, for example, pre-clinical validation. Monitoring for OEM changes to the device. 16
17 Labelling Requirements RSUD s shall be labelled as being reprocessed and shall bear the name and mark of the reprocessor as well as a device identifier specific to the reprocessed version of the SUD. The OEM s information can remain on the device and label for post-market and compatibility issues, but the reprocessor s information shall be prominent. 17
18 Labelling Requirements Reprocessed SUD s shall be permanently marked (indelible ink, laser etching, etc.) to indicate the number of use and reprocessing cycles the devices have undergone. RSUD s are to be labelled to not be re-used and to be returned to the reprocessor. 18
19 Labelling Requirements The labelling / IFU for RSUD s should include details for the initial collection, cleaning, and storage of used devices prior to their return to the reprocessor. Unless deviations are specifically addressed by the reprocessor s objective evidence, the labelling of RSUD s should include the same indications and contraindications, and instructions for use as the OEM device. 19
20 Manufacturing (Reprocessing) Process Collection and Tracking Cleaning Function Testing Packaging Sterilisation
21 Device Tracking Applications for licensing should include descriptions of the collection system and device tracking system that are used. The descriptions should relate to the safety of the device and validations performed. Tracking system Each device is marked with a unique identifier (number) The number of reprocessing cycles the device has undergone is tracked with each device s identifier Tracking will facilitate product identification in case of a recall Tracking will facilitate adverse event reporting
22 Device Tracking Reprocessed SUD s shall be traceable to the OEM device s control number. A recall to the OEM device should be evaluated for applicability to the reprocessed version. Reprocessors are required to have a process to ensure that RSUD s are of a known and valid version / design / configuration / revision. Changes to the OEM device may require revalidations. 22
23 Process Validation - Cleaning Reprocessors are required to perform a thorough validation of cleaning activities / processes. ISO 14937:2009 can be used as a model for the validation of the cleaning process, including: Cleaning agent characterisation Process and equipment characterisation Product definition Process validation, including IQ, OQ, PQ Routine monitoring and control Product release and acceptance Assessment of changes 23
24 Cleaning Validation Cleaning validation should be performed on worst-case scenarios using devices contaminated with artificial test soils. A measured endpoint for the cleaning process is required and should be in accordance with the risk analysis; visually clean is not an acceptable endpoint, nor is a demonstrated reduction in contamination. The validation should address residual contamination by cleaning agents. 24
25 Cleaning Validation The cleaning validation should extend up to the maximum number of re-use cycles that the device may be reprocessed. The cleaning validation can include any refurbishing steps or activities, if applicable. 25
26 Packaging and Shelf Life Validations Reprocessors are required to validate packaging and shelf life, providing the following information in licence applications: Packaging description Packaging and device shelf life Sterile barrier testing Device function testing Validation testing should be performed after environmental conditioning, aging, and transportation simulation. 26
27 Sterilisation Validation Sterilisation processes shall be validated in accordance with applicable standards. This validation should account for re-sterilisation up to the maximum number of re-use cycles. Particular attention should be paid to potentiation to residuals due to repeated sterilisation cycles. Pyrogen testing shall be performed on blood contact / surgically invasive devices, as applicable. 27
28 Device Validation Reprocessors shall have objective evidence of device validation (ref. MDR 9(2), 10-20) post-processing following a maximum number of re-use cycles. This should be in accordance with documented device and performance specifications and the reprocessor s risk analysis. Assessed after maximum number of reprocessing cycles and cycles should be fully simulated (clinical use, cleaning, sterilisation, etc) 28
29 Device Validation Post-processing device validation can take many forms, but should address all relevant aspects, including: Functional testing against specifications (bench testing) Pre-clinical testing (animal studies) Biocompatibility testing Materials Characterisation etc. 29
30 Additional Considerations for RSUDs Other information considered during scientific review: Number of intended reprocessing cycles all validations at maximum Monitoring and tracking OEM device changes Revalidating process when necessary Determining when a licence amendments is required Adverse event reporting Human factors Prions control over any infectious agent that would not be removed by cleaning and sterilisation methods (i.e. TSEs)
31 Summary Reprocessed devices need to meet the requirements of the Regulations and obtain a medical device licence. Emphasis will be placed on the following during review of licence applications: Cleaning validations Device validations following all reprocessing and manufacturing steps (simulated clinical use, cleaning, function testing, packaging, sterilisation, shipping, shelf life, etc) Device tracking Labelling
32 References Notice to Stakeholders - Health Canada's Regulatory Approach to Commercial Reprocessing of Medical Devices Originally Labelled for Single Use March 12, 2015 Medical Device Regulations (SOR/98-282) Guidance for Industry and FDA Staff Medical Device User Fee and Modernization Act of 2002, Validation Data in Premarket Notification Submissions (510(k)s) for Reprocessed Single-Use Medical Devices September 25, 2006 AAMI TIR30:2011 A Compendium of processes, materials, test methods, and acceptance criteria for cleaning reusable medical devices ISO 14937: Sterilization of health care products -- General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices
Notice. For more information on this guidance document, please contact:
July 5, 2012 Notice Our file number: 12-111449-690 Re: : Guidance on supporting evidence to be provided for new and amended licence applications for Class III and Class IV medical devices, not including
More informationISO Part 1 and Part 2 Compliance Requirements. Cathriona O Neill
ISO 11607 Part 1 and Part 2 Compliance Requirements Cathriona O Neill I.S. EN 11607 Introduction ISO 11607 is the principal guidance document. Packaging for terminally sterilised medical devices - Part
More informationReprocessing of Medical Devices: Concerns about Sharps
Reprocessing of Medical Devices: Concerns about Sharps Medical Waste Institute Conference May 7, 2008 Chicago, Illinois Ed Krisiunas, MT(ASCP), CIC, MPH WNWN International Contact Info Ed Krisiunas, MT(ASCP),
More informationOLYMPUS AUG -1 A9 :02
OLYMPUS 4718 11 AUG -1 A9 :02 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm 1061 Rockville, MD 20852 RE: s on Draft Guidance for Industry and FDA Staff " Processing/Reprocessing
More informationMedical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
More informationMarch 6, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org March 6, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration
More informationASTM D10-F02 Workshop FDA Regulatory Perspective. Patrick Weixel FDA Center for Devices and Radiological Health
ASTM D10-F02 Workshop FDA Regulatory Perspective Patrick Weixel FDA Center for Devices and Radiological Health 1 FDA Regulatory Perspective Focus of talk: Use of Standards Auditing Packaging Process Deficiencies
More informationCSA Z314 Series Standards Understanding the Standards
CSA Z314 Series Standards Understanding the Standards September 10,2013 Ian Pequegnat Where do standards come from? What influences their development The International Organization for Standardization
More informationPOSITION PAPER Moving from the MDD to the MDR
A summary of Key Changes regarding Sterile Packaging and considerations on recommended changes to standards Introduction EN ISO 11607 specifies the requirements and test methods for materials, preformed
More informationSteam Sterilization Monitoring in the New CSA Standard (Z )
Speaker Disclaimer Steam Sterilization Monitoring in the New CSA Standard (Z314.3-14) Rick Bauer, Ph.D. Senior Technical Services Advisor 3M Canada Employed in technical services for 3M Canada Education,
More informationValidation of cleaning and sterilization of reusable medical devices
Synergy makes sence Validation of cleaning and sterilization of reusable medical devices MG-FSI72-119 Last revision: June 2012 Aurélien BIGNON 5, Chemin du Catupolan - 69120 Vaulx en Velin - France - Tel.
More informationAnnual EFHSS and MSÜD Conference 2004 Altin Yunus Hotel, Cesme, Izmir, Turkey 5-7 May 2004
Annual EFHSS and MSÜD Conference 2004 Altin Yunus Hotel, Cesme, Izmir, Turkey 5-7 May 2004 Industrial Ethylene Oxide Sterilization of Medical Devices: What Hospitals Need to Know About Re-Sterilization
More informationGuide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994
Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994 SUR-G0006-2 27 AUGUST 2010 This guide does not purport to be an interpretation of law and/or
More informationGHTF Draft Proposal for. Unique Device Identification (UDI) System for Medical Devices
GHTF/AH/(PD2)N2R2 GHTF Draft Proposal for a draft guidance on Unique Device Identification (UDI) System for Medical Devices Authoring Group: GHTF SC UDI AHWG Proposed by the Global Harmonization Task Force
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL MEDICAL DEVICES and IVDs ESSENTIAL PRINCIPLES of SAFETY & PERFORMANCE This guideline is intended to provide recommendations to applicants wishing to sell medical devices and IVDs
More informationAAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1
AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences
More informationEuropean Packaging Regulations What to expect from a notified body audit of your packaging
What to expect from a notified body audit of your packaging Dr. Ralf Walther TÜV Süd Product Service GmbH March 3-5, 2009 www.healthpack.net Content 1. Short introduction of TÜV Süd Product Service 2.
More informationSTERILIZATION VALIDATION IN THIS SECTION REPROCESSING VALIDATIONS FOR REUSABLE MEDICAL DEVICES. Radiation Sterilization Validation
STERILIZATION VALIDATION All sterilization processes require validation of the efficacy and reproducibility of the process. Depending on the type of sterilization, this may be accomplished by partial,
More informationFlexible Endoscopes: The A,B,C s of Monitoring Manual Cleaning Efficacy!
Flexible Endoscopes: The A,B,C s of Monitoring Manual Cleaning Efficacy! Dr. Michelle J. Alfa, Ph.D., FCCM Medical Director, Clinical Microbiology, Diagnostic Services of Manitoba, Winnipeg, Canada Disclaimers:
More informationGUIDELINES ON MEDICAL DEVICES GUIDE FOR COMPETENT AUTHORITIES IN MAKING AN ASSESSMENT OF CLINICAL INVESTIGATION NOTIFICATION
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Cosmetics and Medical Devices MEDDEV 2.7.2 December 2008 GUIDELINES ON MEDICAL DEVICES GUIDE FOR COMPETENT AUTHORITIES IN
More informationDeciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff
Deciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff Document issued on October 25, 2017. The draft of this document was issued
More informationZOLL Document Number: 90E0021 Page 6 of 50 QUALITY SYSTEM MANUAL ZOLL Document Number: 90E0021 Page 7 of 50 1 EXECUTIVE MANAGEMENT APPROVAL... 10 2 INTRODUCTION... 11 3 QUALITY SYSTEM... 12 3.1 QUALITY
More informationPost market Surveillance ISO EU Medical Device Regulation
Post market Surveillance ISO13485 2016 EU Medical Device Regulation Patrick Caines, Ph.D. Baxter Healthcare 15 June 2017 Agenda Post market Regulatory Requirements ISO 13485 2016 Summary of key changes
More informationProcess validation in medical devices
Process validation in medical devices Fulfil requirements with expert regulatory guidance 1TÜV SÜD Contents INTRODUCTION 4 VALIDATION PLANNING 5 INSTALLATION QUALIFICATION 7 OPERATIONAL QUALIFICATION 9
More informationQuality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702
Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 11 Status : APPROVED Effective: 09/07/2017 Page 2 of 32 Quality Manual Table of Contents
More informationGENERAL SURGERY DEVICES
GENERAL SURGERY DEVICES LAPAROSCOPIC INSTRUMENTS SUTURE PASSERS TROCARS ULTRASONIC SCALPELS REPROCESSED SURGICAL DEVICES STRYKER S PORTFOLIO OF REPROCESSED SINGLE-USE DEVICES Laparoscopic devices reprocessed
More informationWhat Dentistry Can Learn from AAMI ST79. Best Practices for device and instrument reprocessing
What Dentistry Can Learn from AAMI ST79 Best Practices for device and instrument reprocessing Learning goals: Purpose and goals of AAMI organization. Overview of ST79. Review selected topics: IFUs, tools
More informationAnnex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
More informationMDR. Device Classification Conformity Assessment Safety & Performance Requirements Technical Documentation
MDR Device Classification Conformity Assessment Safety & Performance Requirements Technical Documentation Suzanne Halliday, D.Phil. Jaishankar Kutty, Ph.D. Ronald Rakos, Ph.D BSI Roadshow, October 2017
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationIf All Else Fails Read the Directions. Disclosure. Manufacturer s Instructions. Presenter: Sue Lafferty CHICA Canada Conference, May 2010
If All Else Fails Read the Directions The Importance of Medical Device Manufacturer s Instructions Presenter: Sue Lafferty CHICA Canada Conference, May 2010 Disclosure Member of 3M Canada Speakers Bureau:
More informationIs contamination of bronchoscopes really a problem?
Is contamination of bronchoscopes really a problem? 1 Is contamination of bronchoscopes really a problem? High Level Disinfection does not methodically clean bronchoscopes What we know 210 More than 210
More informationASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01
ASQ Tappan Zee Section Medical Devices, New Regulations and Standards 26 th September / V. Fischer / Rev. 01 Agenda Medical Device, General Aspects Examples Quality System(s) New Regulations & Standards
More informationLets Talk Indicators Challenging the process Sterilization. ICAN 5 th November Peter Newson
Lets Talk Indicators Challenging the process Sterilization ICAN 5 th November Peter Newson Objectives In the context of the Decontamination process what is an indicator? What phases of the process do we
More informationSterilization Policy. Georgia Regents Medical Center Policy Library. Policy Owner: Epidemiology POLICY STATEMENT
POLICY STATEMENT The ability to sterilize instruments and equipment for use during operative or other invasive procedures is critical to promoting successful patient outcomes and preventing infections.
More informationKorean Medical Devices Regulations
Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,
More informationAn Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs
An Introduction to the Worldwide Regulatory Framework for Medical Devices Elizabeth Malo M.S., Director, Regulatory Affairs Course Outline / Agenda» Overview Device Regulatory Framework» US/EU/Canada Premarket
More informationSoftware Regulation: The Transfusion Medicine Experience
AMIA Invitational Policy Meeting September 9-10, 2009 Software Regulation: The Transfusion Medicine Experience Rodeina Davis Vice President & CIO Milwaukee, WI Founded 60 Years Ago, BloodCenter of Wisconsin
More informationBest Practices for Reprocessing Endoscopes
Best Practices for Reprocessing Endoscopes Reprocessing of Endoscopes Reprocessing Room Standards The resources referenced include: Canadian Standards Association Provincial Infectious Disease Advisory
More informationDRAFT MEDICAL DEVICE GUIDANCE DOCUMENT
November 2015 DRAFT DRAFT MEDICAL DEVICE GUIDANCE DOCUMENT REQUIREMENTS FOR LABELLING OF MEDICAL DEVICES Medical Device Authority MINISTRY OF HEALTH MALAYSIA Contents Page Preface... iii 1 Introduction.
More informationTERMS AND DEFINITIONS
TERMS AND DEFINITIONS Advisory notice A notice issued by the organization, subsequent to delivery of the medical device, to provide supplementary information and/or to advise what action should be taken
More informationMEDICAL DEVICE GUIDANCE
Effective from 1 January 2013 MEDICAL DEVICE GUIDANCE GN-15: Guidance on Medical Device Product Registration Revision 5 CONTENTS 1. INTRODUCTION... 4 1.1. Scope... 5 1.2. Definitions... 5 2. RISK CLASSIFICATION
More informationGetinge da Vinci Solution
Getinge da Vinci Solution A comprehensive cleaning solution for da Vinci EndoWrist instruments This document is intended to provide information to an international audience outside of the US. Validated,
More informationSoftware Recalls Issues and Challenges
ASQ: Meeting the Compliance Challenge Perspectives from Government, Industry and Quality Professionals: April 28, 2010 Software Recalls Issues and Challenges Jeme Wallace Director Regulatory Affairs GE
More informationJanuary 3, AtriCure Inc. Melissa Smallwood Associate Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service January 3, 2017 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 AtriCure
More informationAre you on track for success?
Transitioning from a manual process to automated instrument management Are you on track for success? an ebook from Censis Technologies, Inc. Introduction It is well known that the HITECH Act (Health Information
More informationREUSABLE MEDICAL DEVICE VALIDATION
All sterilization processes require validation of the efficacy and reproducibility of the process. Depending on the type of sterilization, this may be accomplished by partial, sub-lethal, or repetitive
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 11607-2 First edition 2006-04-15 Packaging for terminally sterilized medical devices Part 2: Validation requirements for forming, sealing and assembly processes Emballages des
More informationInternational Standards and EU regulation of medical device software an update
International Standards and EU regulation of medical device software an update Sherman Eagles Partner, SoftwareCPR seagles@softwarecpr.com 612 865 0107 1 Who am I? 18 years at Medtronic, retired 2008 Last
More informationHow to Get ISO Certified
People frequently ask me where to locate information about ISO 13485, so this whitepaper was written specifically to address their needs, as well as review in detail the six steps to preparing for ISO
More informationMedical devices Quality management systems Requirements for regulatory purposes
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 13485 Third edition 2016-03-01 Medical devices Quality management systems Requirements for regulatory purposes Dispositifs médicaux Systèmes de
More informationIMDRF. Final Document. UDI Guidance Unique Device Identification (UDI) of Medical Devices. IMDRF UDI Working Group
IMDRF International Medical Device Regulators Forum Final Document Title: UDI Guidance Unique Device Identification (UDI) of Medical Devices Authoring Group: IMDRF UDI Working Group Date: 9 December 2013
More informationNEMA Standards Publication NEMA/MITA 1. Good Refurbishment Practices for Medical Imaging Equipment
TECHNICAL GUIDE: NEMA Standards Publication NEMA/MITA 1 Good Refurbishment Practices for Medical Imaging Equipment Prepared by DITTA the global voice of diagnostic imaging, radiation therapy, healthcare
More informationPROPOSED REVISED DOCUMENT
SG1(PD)/N011R20 PROPOSED REVISED DOCUMENT Global Harmonization Task Force Title: Summary Technical Documentation for Demonstrating Conformity to the Essential Principles of Safety and Performance of Medical
More informationResponses to Questions for SYSTEM 1E Process Monitoring and Validation Webinar
Responses to Questions for SYSTEM 1E Process Monitoring and Validation Webinar MONITORING THE SYSTEM 1E PROCESSOR Q: I want to confirm that there is no need for a Biological Indicator (BI) and that use
More informationChecklist for the assessment based on the standards
ISO & MDD & Checklist for the assessment based on the standards ISO :2016 ISO :2016 associate with EC Directive 93/42 EEC Where applicable EC Directive 93/42/EEC Annex II/V/VI Company: Audit date Auditor:
More informationDraft Guidance for Industry and FDA Staff Processing/Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling
Draft Guidance for Industry and FDA Staff Processing/Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling DRAFT GUIDANCE This guidance document is being distributed for
More informationMonitoring Flexible Endoscope Channels to Assure Cleaning
Monitoring Flexible Endoscope Channels to Assure Cleaning Dr. Michelle J. Alfa, Ph.D., FCCM Medical Director, Clinical Microbiology, Diagnostic Services of Manitoba, Winnipeg, Canada Disclaimers: Dr. M.
More informationA-M SYSTEMS QUALITY MANUAL
A-M SYSTEMS QUALITY MANUAL ORIGINATED BY: TITLE: DATE: Robert J. Thompson Quality Manager 22-Sept-2011 APPROVED BY: TITLE: DATE: Arthur B. Green III President 22-Sept-2011 Revision History Page: 2 of 32
More informationNotice. Re: GD210: ISO 13485:2003 Quality Management System Audits Performed by Health Canada Recognized Registrars
February 8, 2007 Notice Our file number: 07-103218-349 Re: Performed by Health Canada Recognized Registrars Health Canada is pleased to announce the release of the revised guidance document GD210: ISO
More informationUpdate on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations
Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations Paul Brooks Vice President Healthcare, Americas Presentation to:
More informationMEDICAL DEVICE GUIDANCE
MEDICAL DEVICE GUIDANCE Guidance on Preparation of a Product Registration Submission for General Medical Devices using the ASEAN Common Submission Dossier Template PREFACE This document is intended to
More informationMeeting the challenges of medical device packaging
Meeting the challenges of medical device packaging Gisela Cristina Mendes Bastos Viegas, S.A. October 14, 2011 Agenda Evaluation and selection Validation Test methods Sterile Barrier Systems EN 868 Parts
More informationGUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES
MDEG - 2007-12 - II-3.3 MSOGClassIGuidance_Final GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES Foreword These guidance notes do not aim to be a definite interpretation of National Laws and/or
More informationMEDICAL DEVICE. Technical file.
MEDICAL DEVICE Technical file www.icaro-research.eu ICARO MDTF v1.0 1 Mar 2016 1. Do you plan to launch your medical device in Europe? If you re reading this, chances are good that you re considering introducing
More informationPrecision. Proficiency. Proximity.
Precision. Proficiency. Proximity. Precision Accuracy in testing is paramount to ensuring product safety and efficacy. And fast turnaround times are critical to keeping your project on schedule. With
More informationWork Shop Cleaning Assessment for Introduction of New Equipment, New Product, New Process and Changes Into Licensed Manufacturing Facilities
Work Shop Cleaning Assessment for Introduction of New Equipment, New Product, New Process and Changes Into Licensed Manufacturing Facilities Sanofi Pasteur, Swiftwater, MTech Process Technology, Deputy
More informationMDR ID: Definition: Applicable:
MDR Classification: (Reference Medical Device Regulation EU 2017/745, Annex VIII) Product: Product Name 1. DURATION OF USE MDR ID: Definition: Applicable: - Invasive Device: Continue Go to 2. Invasive
More informationMEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155
MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part
More information21 CFR Ch. I ( Edition) Personnel Design controls Identification Traceability.
Pt. 820 device together with an explanation of the basis for the estimate; (iv) Information describing the applicant s clinical experience with the device since the HDE was initially approved. This information
More information2016. All rights reserved.
DOCUMENT: Future AAMI/ISO 17664, 12 May 2017 Final Draft Standard Sterilization of health care products Information to be provided by the device manufacturer for the processing of medical devices Public
More informationPART 5. Sterilisation Consumables RFTHPV
PART 5 STATEMENT OF REQUIREMENTS Sterilisation Consumables RFTHPV2015 010 Part 5 Statement of Requirements TABLE OF CONTENTS INTRODUCTION... 3 5.1 Purpose... 3 5.2 Scope... 3 5.3 Product Categories...
More informationINTERNATIONAL STANDARDS ON FLUID PREPARATION FOR CONVECTIVE THERAPIES. Richard A. Ward, Ph.D.
INTERNATIONAL STANDARDS ON FLUID PREPARATION FOR CONVECTIVE THERAPIES Richard A. Ward, Ph.D. THE EVOLUTION OF CONVECTIVE THERAPIES Convective therapies enhance large molecule removal by using ultrafiltration
More informationIntroduction to US FDA CDRH Regulations, PMA
Introduction to US FDA CDRH Regulations, PMA Do-Hyun Kim, Ph.D, Ph.D CEO, BT Solutions, Inc. South Korea CEO, Solutions 4BT, LLC, USA The Transformation of Medical Device Industry for Thailand 4.0: Software
More informationPost Market Surveillance
Post Market Surveillance December 6 th, 2017 Michael Maier, Medidee Services Slide 1 Agenda Postmarket surveillance Postmarket clinical follow up (PMCF) Incident reporting What changes with MDR Slide 2
More informationTechnical Guidance on Clinical Evaluation of Medical Devices 1
Technical Guidance on Clinical Evaluation of Medical Devices 1 I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether
More information01.48 Receiving and Processing Vendor Owned Surgical Instrumentation in the Sterile Processing Department
01.48 Receiving and Processing Vendor Owned Surgical Instrumentation in the Purpose To provide effective management of and ensure standardization of processing for all reusable surgical instruments that
More informationOn behalf of the PHSS Pharmaceutical and Healthcare Sciences Society (UK).
31 st March 2015 Submission of comments on ' Concept paper on the revision of annex 1 of the guidelines on good manufacturing practice manufacture of sterile medicinal products EMA/INS/GMP/735037/2014
More informationQuality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:
NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a
More informationEvolution of AAMI/ANSI Standards: Harmonizing with ISO. V. Taaffe 2018
Evolution of AAMI/ANSI Standards: Harmonizing with ISO V. Taaffe 2018 What is AAMI? Association for the Advancement of Medical Instrumentation Nonprofit organization founded in 1967 Diverse community of
More informationMEASURE FOR MEASURE: QUALITY METRICS
MEASURE FOR MEASURE: QUALITY METRICS PDA Midwest Chapter Dinner Meeting, Northbrook, IL-9 November 2017 Felicia Ford-Rice, Director, Strategic Compliance 2017 PAREXEL INTERNATIONAL CORP. AGENDA Robust
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 11607-2 First edition 2006-04-15 Packaging for terminally sterilized medical devices Part 2: Validation requirements for forming, sealing and assembly processes Emballages des
More informationInternational Water Standards
International Water Standards How they effect the design of a water treatment Dr. Stephan Krietemeyer Lauer Membran Wassertechnik GmbH Industriegebiet Speichermatt D 79599 Wittlingen 1 //KR International
More informationISO/TC 198. Secretariat: ANSI
DRAFT INTERNATIONAL STANDARD ISO/DIS 17664 ISO/TC 198 Secretariat: ANSI Voting begins on: Voting terminates on: 2016-04-28 2016-07-27 Processing of health care products Information to be provided by the
More informationMedical Device Biocompatibility: ISO TC194 Overview & Standards
Medical Device Biocompatibility: ISO TC194 Overview & 10993 Standards Jon Cammack, PhD AstraZeneca/MedImmune R&D/Clinical Quality United States Head of Delegation (HoD), ISO TC194 Convenor, ISO TC194/WG15
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation
More informationQualified Persons in the Pharmaceutical Industry Study Guide
Qualified Persons in the Pharmaceutical Industry Study Guide Guide to the knowledge and practical experience required by Qualified Persons relating to pharmaceutical manufacturing in the UK February 2013
More informationImplications of the new MDR from a Product Testing and Certification Perspective
Implications of the new MDR from a Product Testing and Certification Perspective Helping You to Access Global Markets FAST and PREDICTABLY www.test-medical-devices.com 1 Hans Gerd Evering MDR - Implications
More informationIn the huge expanse of Asia, Singapore and
New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets
More informationRe: Docket No. FDA-2009-D-0179, Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org July 27, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
More informationRequirements of validation of packaging systems and sterility assurance
Requirements of validation of packaging systems and sterility assurance Hartmut Dunkelberg University Medical Center, Goettingen, Germany 16th World Sterilization Congress & Annual conference of AFS 7-10
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationTHE REGULATORY PROCESS
THE REGULATORY PROCESS A MANUFACTURER S PERSPECTIVE QRC Consulting Inc Copyrighted 508-259-7374 2 Medical Devices Catheters, monitors, heart valves, etc Cotton Swabs Incontinence pads Tongue depressors
More informationISO : A Risked Based Approach to Biological Safety
ISO 10993 : A Risked Based Approach to Biological Safety Dr Arthur Brandwood Australian Delegation Leader to ISO TC 194 Biocompatibility and Clinical Trials Previous Director Devices Registration and Assessment
More informationPOLICY FOR THE DECONTAMINATION OF FLEXIBLE ENDOSCOPES
POLICY FOR THE DECONTAMINATION OF FLEXIBLE ENDOSCOPES Version 2.0 August 2012 Name of Policy: Purpose of Policy: Policy for the Decontamination of Flexible Endoscopes To provide guidance on the decontamination
More informationFINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports
FINAL DOCUMENT International Medical Device Regulators Forum Title: Authoring Group: Medical Device Regulatory Audit Reports IMDRF MDSAP Working Group Date: 2 October 2015 Toshiyoshi Tominaga, IMDRF Chair
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More informationIAEA SAFETY STANDARDS for protecting people and the environment. Predisposal Management of Radioactive Waste from Nuclear Fuel Cycle Facilities
DS447 Date: 20 February 2015 IAEA SAFETY STANDARDS for protecting people and the environment STATUS: SPESS STEP 12 For submission to CSS Predisposal Management of Radioactive Waste from Nuclear Fuel Cycle
More informationGETTING READY FOR THE EUROPEAN UNION (EU) MEDICAL DEVICE REGULATION (MDR)
GETTING READY FOR THE EUROPEAN UNION (EU) MEDICAL DEVICE REGULATION (MDR) Caroline Leab Abbott Director of Regulatory Affairs David Wolf PTC Program Director of Medical Device Strategy liveworx.com NEW
More information